CIK 0001232524 · Large accelerated filer
Jazz Pharmaceuticals plc
Sign in to watch- Ticker
- JAZZ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- operating
- EIN
- 981032470
- Phone
- 353-1-634-7800
- Business address
- FIFTH FLOOR, WATERLOO EXCHANGE, WATERLOO ROAD, DUBLIN, Ireland, D04 E5W7
- Former names
- JAZZ PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,420,682
- in 10 filings, $24.9M under 10b5-1 plans
Net −$41,420,682. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- COZADD BRUCE C −$20.4M Director sold 20% of stake
- Iannone Robert −$19.2M EVP, Global Head of R&D & CMO sold 54% of stake
- GALA RENEE D −$1.2M President & CEO sold 3% of stake
- Carr Patricia −$327K SVP, Chief Accounting Officer sold 18% of stake
- Patil Neena M −$289K EVP & Chief Legal Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-08 | Mulligan Seamus Director | Option exercise | +4,500 | $81.76 | $368K | 1,169,300 |
| 2023-06-08 | Mulligan Seamus Director | Option exercise · Non-Qualified Stock Option (right to buy) | −4,500 | 0 | ||
| 2023-06-07 | Carr Patricia SVP, Chief Accounting Officer | Sale | −126 | $127.92 | $16K | 6,286 |
| 2023-06-05 | Iannone Robert EVP, Global Head of Research a | Returned to the company | −1,311 | $129.73 | $170K | 45,315 |
| 2023-06-05 | Sablich Kim EVP, GM of U.S. | Returned to the company | −2,082 | $129.73 | $270K | 28,478 |
| 2023-06-01 | Patil Neena M EVP & Chief Legal Officer | Sale | −1,526 | $127.98 | $195K | 32,900 |
| 2023-06-01 | Patil Neena M EVP & Chief Legal Officer | Sale | −74 | $128.02 | $9K | 32,826 |
| 2023-05-18 | GALA RENEE D EVP & Chief Financial Officer | Sale | −6,000 | $131.75 | $790K | 35,978 |
| 2023-04-05 | GALA RENEE D EVP & Chief Financial Officer | Shares withheld for taxes | −1,807 | $145.78 | $263K | 41,978 |
| 2023-03-15 | Carr Patricia SVP, Chief Accounting Officer | Sale | −1,023 | $133.22 | $136K | 6,286 |
| 2023-03-08 | Sablich Kim EVP, GM of U.S., Commercial Ma | Sale | −1,752 | $139.42 | $244K | 31,821 |
| 2023-03-08 | Sablich Kim EVP, GM of U.S., Commercial Ma | Sale | −1,261 | $140.19 | $177K | 30,560 |
| 2023-03-07 | O'Keefe Kenneth W Director | Option exercise | +4,500 | $81.76 | $368K | 25,579 |
| 2023-03-07 | O'Keefe Kenneth W Director | Sale | −2,690 | $138.39 | $372K | 22,889 |
| 2023-03-07 | O'Keefe Kenneth W Director | Option exercise · Non-Qualified Stock Option (right to buy) | −4,500 | 0 | ||
| 2023-03-07 | Larkin Finbar SVP, Technical Operations | Sale | −2,075 | $140.76 | $292K | 21,779 |
| 2023-03-06 | Larkin Finbar SVP, Technical Operations | Option exercise | +1,706 | $58.72 | $100K | 25,560 |
| 2023-03-06 | Larkin Finbar SVP, Technical Operations | Sale | −1,706 | $143.92 | $246K | 23,854 |
| 2023-03-06 | Larkin Finbar SVP, Technical Operations | Option exercise · Non-Qualified Stock Option (right to buy) | −1,706 | 0 | ||
| 2023-03-05 | Swisher Daniel N JR President and COO | Shares withheld for taxes | −5,426 | $142.78 | $775K | 55,014 |
Page 19 of 31 · 614 trades